Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
9
GPCR Quote, Financials, Valuation and Earnings
Last price:
$19.55
Seasonality move
:
32.88%
Day range:
$18.94 - $19.74
52-week range:
$13.22 - $45.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.37x
Volume:
544.9K
Avg. volume:
766K
1-year change:
-56.11%
Market cap:
$1.1B
Revenue:
--
EPS (TTM):
-$2.59
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.4M | $29.1M | $36.2M | $70.1M | $108.8M | |
| Selling, General & Admin | $3.5M | $8.6M | $16.4M | $32.7M | $49.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $15.9M | $37.7M | $52.6M | $102.8M | $158.2M | |
| Operating Income | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$15.7M | -$37.8M | -$51.3M | -$89.4M | -$122.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $138K | $231K | $17K | $236K | $310K | |
| Net Income to Company | -$15.9M | -$38M | -$51.3M | -$89.6M | -$122.5M | |
| Minority Interest in Earnings | -- | -$2M | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$16M | -$40M | -$51.3M | -$89.6M | -$122.5M | |
| Basic EPS (Cont. Ops) | -$0.64 | -$1.72 | -$1.38 | -$2.43 | -$2.34 | |
| Diluted EPS (Cont. Ops) | -$0.64 | -$1.72 | -$1.38 | -$2.43 | -$2.34 | |
| Weighted Average Basic Share | $25.1M | $25.5M | $38.2M | $36.7M | $52.6M | |
| Weighted Average Diluted Share | $25.1M | $25.5M | $38.2M | $36.7M | $52.6M | |
| EBITDA | -$15.9M | -$37.6M | -$52.3M | -$102.5M | -$157.2M | |
| EBIT | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Operating Income (Adjusted) | -$15.9M | -$37.7M | -$52.6M | -$102.8M | -$158.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $8.5M | $13.1M | $20.7M | $42.9M | |
| Selling, General & Admin | -- | $4.5M | $6.5M | $11.3M | $13.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $13M | $19.6M | $32M | $56.3M | |
| Operating Income | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$13M | -$18M | -$26M | -$46.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $60K | $25K | $29K | $98K | |
| Net Income to Company | -- | -$13.1M | -$18M | -$26M | -$46.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$13.1M | -$18M | -$26M | -$46.8M | |
| Basic EPS (Cont. Ops) | -- | -$0.51 | -$0.75 | -$0.57 | -$0.81 | |
| Diluted EPS (Cont. Ops) | -- | -$0.51 | -$0.75 | -$0.57 | -$0.81 | |
| Weighted Average Basic Share | -- | $25.5M | $23.9M | $46.6M | $57.4M | |
| Weighted Average Diluted Share | -- | $25.5M | $23.9M | $46.6M | $57.4M | |
| EBITDA | -- | -$12.9M | -$19.6M | -$31.8M | -$56M | |
| EBIT | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Operating Income (Adjusted) | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $40.8M | $77.6M | $131M | |
| Selling, General & Admin | -- | -- | $18.4M | $37.5M | $51.5M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | $59.3M | $115.1M | $182.5M | |
| Operating Income | -- | -- | -$59.3M | -$115.1M | -$182.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$56.2M | -$97.4M | -$142.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$18K | $240K | $379K | |
| Net Income to Company | -- | -- | -$56.2M | -$97.7M | -$143.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$56.2M | -$97.7M | -$143.3M | |
| Basic EPS (Cont. Ops) | -- | -- | -$2.15 | -$2.28 | -$2.59 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$2.15 | -$2.28 | -$2.59 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$59M | -$114.7M | -$181.5M | |
| EBIT | -- | -- | -$59.3M | -$115.1M | -$182.5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$59.3M | -$115.1M | -$182.5M | |
| Operating Income (Adjusted) | -- | -- | -$59.3M | -$115.1M | -$182.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $8.5M | $13.1M | $20.7M | $42.9M | |
| Selling, General & Admin | -- | $4.5M | $6.5M | $11.3M | $13.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $13M | $19.6M | $32M | $56.3M | |
| Operating Income | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$13M | -$18M | -$26M | -$46.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $60K | $25K | $29K | $98K | |
| Net Income to Company | -- | -$13.1M | -$18M | -$26M | -$46.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$13.1M | -$18M | -$26M | -$46.8M | |
| Basic EPS (Cont. Ops) | -- | -$0.51 | -$0.75 | -$0.57 | -$0.81 | |
| Diluted EPS (Cont. Ops) | -- | -$0.51 | -$0.75 | -$0.57 | -$0.81 | |
| Weighted Average Basic Share | -- | $25.5M | $23.9M | $46.6M | $57.4M | |
| Weighted Average Diluted Share | -- | $25.5M | $23.9M | $46.6M | $57.4M | |
| EBITDA | -- | -$12.9M | -$19.6M | -$31.8M | -$56M | |
| EBIT | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Operating Income (Adjusted) | -- | -$13M | -$19.6M | -$32M | -$56.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.4M | $105.3M | $26.1M | $129.8M | $169.5M | |
| Short Term Investments | $21.1M | $2M | $64.8M | $337.5M | $714M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $974K | $1.9M | $2.2M | $6.3M | $7.7M | |
| Total Current Assets | $38.4M | $109.3M | $93.1M | $473.6M | $891.2M | |
| Property Plant And Equipment | $277K | $1.8M | $1.3M | $8.4M | $7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $8K | $111K | $3.5M | $45K | $5.1M | |
| Total Assets | $38.7M | $111.2M | $97.8M | $482M | $903.3M | |
| Accounts Payable | $1.5M | $3.5M | $6M | $4.7M | $8M | |
| Accrued Expenses | $408K | $2.7M | $3M | $14.2M | $19M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $147K | $349K | $260K | $1.4M | $1.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3M | $8.7M | $13M | $24.7M | $36M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $61.2M | $175.9M | $213M | $29.1M | $38.5M | |
| Common Stock | $1K | $1K | $1K | $14K | $17K | |
| Other Common Equity Adj | -$1K | -- | -$110K | $521K | $914K | |
| Common Equity | -$22.5M | -$64.7M | -$115.1M | $453M | $864.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$22.5M | -$64.7M | -$115.1M | $453M | $864.8M | |
| Total Liabilities and Equity | $38.7M | $111.2M | $97.8M | $482M | $903.3M | |
| Cash and Short Terms | $37.4M | $107.3M | $90.8M | $467.3M | $883.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $126.5M | $97.8M | $152.1M | |
| Short Term Investments | -- | -- | $114.4M | $338.6M | $684.8M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $5.3M | $12.9M | $12.7M | |
| Total Current Assets | -- | -- | $246.2M | $449.4M | $849.6M | |
| Property Plant And Equipment | -- | -- | $1.1M | $7.8M | $10.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $59K | $47K | $6.1M | |
| Total Assets | -- | -- | $247.4M | $457.2M | $866.5M | |
| Accounts Payable | -- | -- | $4.9M | $6.5M | $8.7M | |
| Accrued Expenses | -- | -- | $4.5M | $13.1M | $20.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $168K | $1.6M | $2.5M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $11M | $23.6M | $36.5M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $11M | $27.4M | $41.9M | |
| Common Stock | -- | -- | $11K | $14K | $17K | |
| Other Common Equity Adj | -- | -- | $147K | -$90K | $815K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $236.4M | $429.8M | $824.6M | |
| Total Liabilities and Equity | -- | -- | $247.4M | $457.2M | $866.5M | |
| Cash and Short Terms | -- | -- | $240.9M | $436.4M | $836.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.9M | -$38M | -$51.3M | -$89.6M | -$122.5M | |
| Depreciation & Amoritzation | -- | $72K | $277K | $295K | $992K | |
| Stock-Based Compensation | $570K | $1.5M | $2.5M | $8.2M | $18.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$14.3M | -$32.2M | -$46.1M | -$79.5M | -$116.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$21.1M | $17.9M | -$62.1M | -$268.3M | -$358.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$115K | -$2.5M | -$21.6M | -$1.8M | |
| Cash From Financing | $25.8M | $103.3M | $29M | $451.5M | $515.3M | |
| Beginning Cash (CF) | $25.9M | $16.4M | $105.3M | $26.1M | $129.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$9.6M | $89M | -$79.2M | $103.7M | $39.7M | |
| Ending Cash (CF) | $16.4M | $105.3M | $26.1M | $129.8M | $169.5M | |
| Levered Free Cash Flow | -$14.3M | -$33.4M | -$46.3M | -$81.7M | -$117.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$13.1M | -$18M | -$26M | -$46.8M | |
| Depreciation & Amoritzation | -- | $70K | $70K | $222K | $274K | |
| Stock-Based Compensation | -- | $620K | $2.5M | $2.7M | $5.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$13.5M | -$20.3M | -$34.1M | -$52.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$39.7M | -$49M | $1.4M | $34M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.4M | -$2.6M | -$53K | -$156K | |
| Cash From Financing | -- | -$1.4M | $169.7M | $702K | $809K | |
| Beginning Cash (CF) | -- | $105.3M | $26.1M | $129.8M | $169.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$54.7M | $100.4M | -$32M | -$17.4M | |
| Ending Cash (CF) | -- | $50.6M | $126.5M | $97.8M | $152.1M | |
| Levered Free Cash Flow | -- | -$13.6M | -$20.3M | -$34.2M | -$52.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$56.2M | -$97.7M | -$143.3M | |
| Depreciation & Amoritzation | -- | -- | $277K | $447K | $1M | |
| Stock-Based Compensation | -- | $620K | $4.4M | $8.4M | $22M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$52.9M | -$93.3M | -$134.8M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$71.4M | -$217.9M | -$326.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$3.7M | -$19M | -$1.9M | |
| Cash From Financing | -- | -- | $200.2M | $282.5M | $515.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $75.9M | -$28.7M | $54.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$53M | -$95.6M | -$136.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$13.1M | -$18M | -$26M | -$46.8M | |
| Depreciation & Amoritzation | -- | $70K | $70K | $222K | $274K | |
| Stock-Based Compensation | -- | $620K | $2.5M | $2.7M | $5.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$13.5M | -$20.3M | -$34.1M | -$52.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$39.7M | -$49M | $1.4M | $34M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.4M | -$2.6M | -$53K | -$156K | |
| Cash From Financing | -- | -$1.4M | $169.7M | $702K | $809K | |
| Beginning Cash (CF) | -- | $105.3M | $26.1M | $129.8M | $169.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$54.7M | $100.4M | -$32M | -$17.4M | |
| Ending Cash (CF) | -- | $50.6M | $126.5M | $97.8M | $152.1M | |
| Levered Free Cash Flow | -- | -$13.6M | -$20.3M | -$34.2M | -$52.5M | |
Get GPCR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GPCR
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
1.37x
1.80x
Price / LTM sales
--
1.65x
Growth Metrics
GPCR
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
-$0.36
-$0.20
Profitability
GPCR
Sector
Profitability FY 2025
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
7
Balance Sheet
GPCR
Sector
Total cash
$836.9M
$35.5M
Short term investments
$714M
$29.7M
Total assets
$903.3M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
